首页> 外文期刊>Diabetes technology & therapeutics >Insulin pump therapy management in very young children with type 1 diabetes using continuous subcutaneous insulin infusion.
【24h】

Insulin pump therapy management in very young children with type 1 diabetes using continuous subcutaneous insulin infusion.

机译:使用连续皮下胰岛素输注治疗非常年轻的1型糖尿病儿童的胰岛素泵治疗管理。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Compared to older children and adolescents very young patients with type 1 diabetes represent a unique population. We analyzed the age-dependent characteristics and parameters of continuous subcutaneous insulin infusion (CSII) in children under 6 years of age with type 1 diabetes. METHODS: We evaluated metabolic control and pump-dependent characteristics in 46 children with type 1 diabetes after 0.89 +/- 0.62 years of CSII. RESULTS: Metabolic control significantly improved after CSII initiation (glycosylated hemoglobin, 8.12 +/- 1.24% vs. 7.30 +/- 0.67%; P < 0.05), without increased risk for diabetic ketoacidosis or hypoglycemia. Interestingly, very young patients required bigger boluses than expected, especially in the morning and at the afternoon snack. CONCLUSIONS: These data support the need to personalize pump-dependent characteristics, especially in very young children with type 1 diabetes, in order to optimize CSII therapy in this unique age group of patients.
机译:背景:与年龄较大的儿童和青少年相比,非常年轻的1型糖尿病患者代表着独特的人群。我们分析了6岁以下1型糖尿病儿童的连续皮下胰岛素输注(CSII)的年龄依赖性特征和参数。方法:我们评估了46名1型糖尿病儿童的CSII在0.89 +/- 0.62年后的代谢控制和泵依赖性特征。结果:CSII开始后代谢控制显着改善(糖基化血红蛋白,8.12 +/- 1.24%vs. 7.30 +/- 0.67%; P <0.05),而没有糖尿病酮症酸中毒或低血糖的风险增加。有趣的是,非常年轻的患者需要比预期更大的大剂量,特别是在早晨和下午的零食中。结论:这些数据支持个性化泵依赖性特征的需求,特别是在1型糖尿病的年幼儿童中,以便在这种独特年龄组的患者中优化CSII治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号